An overview of the WIN consortium

The WIN symposium 2019

KEYNOTE-028 and KEYNOTE-158: Pembrolizumab as treatment for advanced SCLC after two or more lines of prior therapy

HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma

New developments in soft tissue and bone sarcoma research

Updates from the BCON trial: Longterm outcomes of hypoxia modification in bladder preservation

Adjuvant sequential chemotherapy plus radiotherapy for LABC after radical cystectomy: Urothelial carcinoma subgroup analysis

KEYNOTE-365 Cohort A: Pembrolizumab plus olaparib in docetaxel-pretreated patients with mCRPC

Analysis of acute toxicity from PACE-B: Comparing SBRT to CFMHRT for localised prostate cancer

BGICC 2019

Superparamagnetic iron oxide nanoparticles for sentinel node biopsy

Fertility issues during adjuvant treatment in premenopausal breast cancer patients